DGF — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesIsrael, IL
Eran Eden(Co-founder and CEO)in
BoardOri Hadomi(Chairman of the Board of Directors)
Co-investorsDNA CapitalHorizons VenturesMetaplanetQualcomm VenturesUnion Tech VenturesWestern Technology Investment+4 more
Memed operates a digital prescription platform in Brazil that connects physicians, patients, pharmacies, pharmaceutical companies, and health institutions.
Digital HealthHealthtechSaaS
Marcel Ribeiro(Founder)inRicardo Moraes(Founder)inRené Moraes(Founder)in
Co-investorsMONASHEESBridge OneDNA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





